A clinical trial of a new drug designed to treat hypertension (high blood pressure) is designed to last for three years, but after the first year it becomes clear that the drug is highly successful. Is it ethical to continue the trial with the result that some hypertensive subjects continue to receive a placebo instead of the effective treatment?